Anjali Verma
Affiliations: | 2019- | University of North Carolina at Chapel Hill Eshelman School of Pharmacy |
Google:
"Anjali Verma"Bio:
Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Barbara D. Boyan | grad student | 2015-2019 | VCU | |
| Zvi Schwartz | grad student | 2015-2019 | VCU | |
| (ERα isoforms modulate the tumorigenicity of 24R,25(OH)2D3 in estrogen-responsive cancer) | ||||
| Juliane Nguyen | post-doc | 2019-2020 | UNC Chapel Hill | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Verma A, Cohen DJ, Jacobs TW, et al. (2020) The Relative Expression of ERα Isoforms ERα66 and ERα36 Controls the Cellular Response to 24R,25-Dihydroxyvitamin D3 in Breast Cancer. Molecular Cancer Research : McR |
| Wang J, Lee CJ, Deci MB, et al. (2020) MiR-101a loaded extracellular Nanovesicles as bioactive carriers for cardiac repair. Nanomedicine : Nanotechnology, Biology, and Medicine. 102201 |
| Verma A, Schwartz N, Cohen DJ, et al. (2020) Loss of Estrogen Receptors is Associated with Increased Tumor Aggression in Laryngeal Squamous Cell Carcinoma. Scientific Reports. 10: 4227 |
| Verma A, Schwartz N, Cohen DJ, et al. (2019) Estrogen signaling and estrogen receptors as prognostic indicators in laryngeal cancer. Steroids. 108498 |
| Verma A, Schwartz Z, Boyan BD. (2019) 24R,25-dihydroxyvitamin D3 modulates tumorigenicity in breast cancer in an estrogen receptor-dependent manner. Steroids. 108447 |
| Verma A, Cohen DJ, Schwartz N, et al. (2019) 24R,25-Dihydroxyvitamin D regulates breast cancer cells in vitro and in vivo. Biochimica Et Biophysica Acta. General Subjects |
| Verma A, Cohen DJ, Muktipaty C, et al. (2019) Abstract 2133: 24R,25(OH)2D3is differentially tumorigenic in ER+ and ER- breast cancer Cancer Research |
| Verma A, Cohen DJ, Muktipaty C, et al. (2018) Abstract 3845: 24R,25-Dihydroxyvitamin D3 reduces tumor burden and metastasis in ER+ breast cancer in vivo Cancer Research. 78: 3845-3845 |
| Schwartz N, Verma A, Muktipaty C, et al. (2017) Estradiol Receptor Profile and Estrogen Responsiveness in Laryngeal Cancer and Clinical Outcomes. Steroids |
| Cohen DJ, Patel V, Verma A, et al. (2017) Effect of 17β-Estradiol on Estrogen Receptor Negative Breast Cancer Cells in an Osteolytic Mouse Model. Steroids |